Viola Vitalis AB

Founded in 2010, Viola Vitalis AB develops and disseminates leading-edge innovative technology, methodology, and nutraceuticals gloabally. We have carried out successful projects, collaborated with renowned organizations, and delivered services and solutions worldwide in the field of scientific and industrial research. In collaboration with preeminent global innovation leaders, we have developed effective nutraceuticals, mediated sales of state-of-the-art healthcare technologies and laboratory equipment, and provided analytical services. Viola Vitalis AB initiated the development of a turnkey system for human milk banks leveraging state-of-the-art technology to help minimize infant mortality, particularly among preterm infants. The prime purpose of our research on nutraceuticals is to develop sustainable protection against chronic diseases such as Arsenicosis, affecting over 100 million people globally.